- Home
- HIO vs ALEC Comparison
HIO vs ALEC Comparison
Compare HIO & ALEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | HIO | ALEC |
|---|---|---|
| Founded | 1993 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance/Investors Services | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 335.7M | 275.8M |
| IPO Year | N/A | 2019 |
Fundamental Metrics
Financial Performance| Metric | HIO | ALEC |
|---|---|---|
| Price | $3.41 | $2.00 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $4.83 |
| AVG Volume (30 Days) | 399.9K | ★ 1.6M |
| Earning Date | 01-01-0001 | 05-04-2026 |
| Dividend Yield | ★ 10.33% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $21,045,000.00 |
| Revenue This Year | N/A | $2.03 |
| Revenue Next Year | N/A | $29.87 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $3.43 | $1.09 |
| 52 Week High | $4.05 | $3.40 |
Technical Indicators
Market Signals| Indicator | HIO | ALEC |
|---|---|---|
| Relative Strength Index (RSI) | 26.58 | 44.70 |
| Support Level | N/A | $1.93 |
| Resistance Level | $3.69 | $2.10 |
| Average True Range (ATR) | 0.03 | 0.21 |
| MACD | -0.00 | -0.07 |
| Stochastic Oscillator | 35.63 | 6.45 |
Price Performance
Historical ComparisonAbout HIO Western Asset High Income Opportunity Fund Inc.
Western Asset High Income Oppor Fd Inc is a diversified closed-end management investment company. The company's primary objective is to seek high current income and the secondary objective is capital appreciation. It invests a majority of its net assets in high-yield corporate debt securities and the rest in common stock equivalents, including options, warrants, and rights. The company invests in securities of companies from various sectors such as energy, technology, utilities, industrials, communications, finance, and capital goods among others.
About ALEC Alector Inc.
Alector Inc is a clinical-stage biotechnology company focused on developing therapies for neurodegenerative diseases. The company advances a pipeline of product candidates including Nivisnebart (AL101/GSK4527226) for Alzheimer's disease, AL137 for Alzheimer's disease, AL050 for Parkinson's disease and Lewy body dementia, and AL064, an siRNA program targeting tau for Alzheimer's disease and other tauopathies, supported by its proprietary Alector Brain Carrier (ABC) platform designed to improve delivery of therapeutics across the blood-brain barrier.